![Zoltán Czigler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zoltán Czigler
Director of Finance/CFO at Anergis SA
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Francois Spertini | M | - |
Anergis SA
![]() Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | 23 years |
Jeffrey Berg | M | 77 | 27 years | |
Maria Smith | F | 58 | 25 years | |
Markus Hosang | M | - |
Anergis SA
![]() Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | - |
Klaus Schollmeier | M | 67 |
Anergis SA
![]() Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | - |
Sten Verland | M | 67 |
Anergis SA
![]() Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | - |
Arnd Kaltofen-Ehmann | M | 64 |
VI Partners AG
![]() VI Partners AG Investment ManagersFinance VI Partners AG (VI Partners) is an independent venture capital firm founded in 2001. The firm is headquartered in Schwyz, Switzerland. | 23 years |
Alain Nicod | M | 64 |
VI Partners AG
![]() VI Partners AG Investment ManagersFinance VI Partners AG (VI Partners) is an independent venture capital firm founded in 2001. The firm is headquartered in Schwyz, Switzerland. | 22 years |
Diego Braguglia | M | 58 |
VI Partners AG
![]() VI Partners AG Investment ManagersFinance VI Partners AG (VI Partners) is an independent venture capital firm founded in 2001. The firm is headquartered in Schwyz, Switzerland. | 21 years |
Wim A. Coekaerts | M | - | 29 years | |
Vincent Charlon | M | - |
Anergis SA
![]() Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | 15 years |
Vanya Beltrami | M | - |
Anergis SA
![]() Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | 10 years |
Gerard Farmer | M | - |
Anergis SA
![]() Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | 13 years |
Alexander Kettner | M | - |
Anergis SA
![]() Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gerald Held | M | 76 | 4 years | |
Daniel Cooperman | M | 73 | 10 years | |
Fritz Kunz | M | - |
Kuros Biosurgery Holding AG
![]() Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | - |
Raymond L. Ocampo | M | 71 | 10 years | |
Frank O’Dowd | M | 66 | 22 years | |
Juliette Rizkallah | F | 57 | 6 years | |
Tony Ayaz | M | - | 3 years | |
Gary D. Chancellor | M | - | 5 years | |
Timo Lehes | M | 58 |
Speed Ventures AB (Old)
| 1 years |
Chirantan Desai | M | 53 | 7 years | |
John Boucher | M | 60 | 14 years | |
Ramon Chen | M | - | 2 years | |
Laurent Sandrolini | M | - | 10 years | |
Klaus Holse | M | 63 | 4 years | |
Sanjay Bhasin | M | - | 7 years | |
Mike Seidenberg | M | - | 4 years | |
Juan F. Rada | M | - | - | |
Bud Langston | M | - | - | |
Peter Doolan | M | - | 15 years | |
Ravi Thakur | M | 49 | 10 years | |
Peter Lee | M | - | 8 years | |
Sang Na | M | - | 9 years | |
Zachary Nelson | M | 62 | 4 years | |
Bhagat Nainani | M | - | 18 years | |
Radhakrishna Rao | M | 58 | 6 years | |
Raghu Iyer | M | - | 4 years | |
Petrina Thomson | F | 56 | 14 years | |
Doug Kennedy | M | - | 21 years | |
Joseph M. Auriemma | M | - | 6 years | |
Lei Tung | M | - | 5 years | |
Linda Mihalic | F | 53 | 19 years | |
Mike Stone | M | - | 8 years | |
Srinivasa Pendyala | M | 58 | 4 years | |
Shelly Kapoor Collins | F | - | 10 years | |
Ho-Ki Au | M | - | 4 years | |
Anne DelSanto | F | 60 | 13 years | |
Monica Kumar | F | - | 22 years | |
Thomas Marth | M | 59 | 16 years | |
Jeb Dasteel | M | - | 21 years | |
Adrian Suherman | M | 51 | 7 years | |
Georgia Keohane | F | 51 | 4 years | |
Leslie Campbell | F | 65 | 8 years | |
Mark Nelson | M | 54 | 16 years | |
Claus Moldt | M | 61 | 9 years | |
Jeff Hallowell | M | - | 4 years | |
Douglas Finlay | M | - | 15 years | |
Bobby Yazdani | M | 60 | 8 years | |
Joseph E. Duffy | M | 66 | 7 years | |
Sergio Giacoletto-Roggio | M | 75 | 11 years | |
Arvind Relan | M | 61 | 4 years | |
Sammy Oh | M | - | - | |
Robert W. Shaw | M | 76 | 6 years | |
Marty J. Beard | M | 60 | 3 years | |
Edward J. Sanderson | M | 75 | 7 years | |
David Roux | M | 67 | 4 years | |
Jim Cavalieri | M | 53 | 4 years | |
Robert P. Hughes | M | 64 | 6 years | |
John Dorman | M | 73 | 21 years | |
Andrew Laursen | M | - | 10 years | |
Farzad Nazem | M | 62 | 11 years | |
Frederick R Dewey | M | - | 5 years | |
Michael L. Graves | M | 53 | 10 years | |
Marc L. Rose | M | 59 | 3 years | |
Jeremy Burton | M | 56 | 4 years | |
Frank Slayne | M | - | 6 years | |
Steffan Tomlinson | M | 52 | 4 years | |
Antonio Casacuberta | M | 64 | 10 years | |
Doug Renert | M | - | 8 years | |
Sandra Taylor | F | 62 | 3 years | |
Soulaiman Htite | M | 51 | 10 years | |
Dune Thorne | F | - | 2 years | |
Gary Damiano | M | - | 11 years | |
David Orrico | M | - | 7 years | |
H. Alex Aminian | M | - | 3 years | |
Mitch Wallace | M | - | 7 years | |
Mrinal Chatterjee | M | - | 3 years | |
David Canellos | M | 58 | - | |
Noreen L. Henrich | F | 67 | 5 years | |
Gary Dannatt | M | 53 | - | |
John Wookey | M | 65 | - | |
Jean Sini | M | - | 8 years | |
John David Reuben | M | - | 3 years | |
David Pendergast | M | - | 6 years | |
Joseph D. Morrone | M | - | - | |
Daniel K. Lim | M | - | - | |
Var George | M | - | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 87 | 87.00% |
Switzerland | 12 | 12.00% |
Sweden | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Zoltán Czigler
- Personal Network